Literature DB >> 16458140

Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.

Takayoshi Tsutamoto1, Atsuyuki Wada, Hiroshi Sakai, Chitose Ishikawa, Toshinari Tanaka, Masaru Hayashi, Masanori Fujii, Takashi Yamamoto, Tomohiro Dohke, Masato Ohnishi, Hiroyuki Takashima, Masahiko Kinoshita, Minoru Horie.   

Abstract

OBJECTIVES: This study sought to evaluate the relationship between brain natriuretic peptide (BNP), renal function, and the severity of congestive heart failure (CHF).
BACKGROUND: Both BNP and renal function are prognostic predictors in CHF patients.
METHODS: We measured the plasma BNP level in the aortic root and coronary sinus in 366 consecutive patients with CHF. Estimated glomerular filtration rate (eGFR) by the Cockcroft-Gault equation was used as an indicator of renal function.
RESULTS: By stepwise multivariate analyses, hemodynamic parameters such as left ventricular ejection fraction (LVEF) and left ventricular end-diastolic pressure (LVEDP) but not eGFR were independent predictors of a transcardiac increase (coronary sinus-aortic root) in BNP. Regarding the plasma level of BNP in the aortic root, not only LVEF (p < 0.0001) and LVEDP (p < 0.0001) but also eGFR (p < 0.0001) were independent predictors. Patients were divided into two groups, patients with an eGFR > or =60 ml/min (group 1, n = 229) and patients with an eGFR <60 ml/min (group 2, n = 137). There was no difference in LVEF, LVEDP, or the transcardiac gradient of BNP between the two groups, but the plasma level of BNP in the aortic root was approximately two-fold greater in group 2 than in the group 1.
CONCLUSIONS: These findings suggest that decreased clearance from the kidney contributes to the elevated BNP in CHF patients with renal dysfunction, especially in patients with an eGFR <60 ml/min.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458140     DOI: 10.1016/j.jacc.2005.10.038

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  42 in total

Review 1.  Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Authors:  Chaitanya Madamanchi; Hassan Alhosaini; Arihiro Sumida; Marschall S Runge
Journal:  Int J Cardiol       Date:  2014-08-09       Impact factor: 4.164

2.  Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS.

Authors:  Nirav Patel; Mary Cushman; Orlando M Gutiérrez; George Howard; Monika M Safford; Paul Muntner; Raegan W Durant; Sumanth D Prabhu; Garima Arora; Emily B Levitan; Pankaj Arora
Journal:  JCI Insight       Date:  2019-06-04

3.  Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure.

Authors:  Hsin-Fu Lee; Lung-An Hsu; Chi-Jen Chang; Yi-Hsin Chan; Chun-Li Wang; Wan-Jing Ho; Pao-Hsien Chu
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-18       Impact factor: 2.357

4.  Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.

Authors:  Alison Morris; Matthew R Gingo; M Patricia George; Lorrie Lucht; Cathy Kessinger; Vikas Singh; Maria Hillenbrand; Michelle Busch; Deborah McMahon; Karen A Norris; Hunter C Champion; Mark T Gladwin; Yingze Zhang; Chad Steele; Frank C Sciurba
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

5.  B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS.

Authors:  Matthew W Semler; Annis M Marney; Todd W Rice; Hui Nian; Chang Yu; Arthur P Wheeler; Nancy J Brown
Journal:  Chest       Date:  2016-03-23       Impact factor: 9.410

6.  Accessory pathway location affects brain natriuretic peptide level in patients with Wolff-Parkinson-White syndrome.

Authors:  Yosuke Nakatani; Koji Kumagai; Shigeto Naito; Kohki Nakamura; Kentaro Minami; Masahiro Nakano; Takehito Sasaki; Koichiro Kinugawa; Shigeru Oshima
Journal:  J Interv Card Electrophysiol       Date:  2016-11-04       Impact factor: 1.900

Review 7.  Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

Authors:  Thanat Chaikijurajai; Hernan Rincon Choles; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-09-17

8.  Contributors to diffusion impairment in HIV-infected persons.

Authors:  Matthew R Gingo; Jiayan He; Catherine Wittman; Carl Fuhrman; Joseph K Leader; Cathy Kessinger; Lorrie Lucht; William A Slivka; Yingze Zhang; Deborah K McMahon; Frank C Sciurba; Alison Morris
Journal:  Eur Respir J       Date:  2013-02-21       Impact factor: 16.671

9.  Attenuation of post-shock increases in brain natriuretic Peptide with post shock overdrive pacing.

Authors:  Marco Budeus; Emanuel Salibassoglu; Anna Maria Schymura; Nico Reinsch; Nils Lehmann; Heinrich Wieneke; Stefan Sack; Raimund Erbel
Journal:  Indian Pacing Electrophysiol J       Date:  2010-03-05

Review 10.  Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies.

Authors:  Janaka Karalliedde; Robin E Buckingham
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.